IgA Nephropathy American Journal of Kidney Diseases

Slides:



Advertisements
Similar presentations
Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad Najafian, MD, Charles E
Advertisements

Behzad Najafian, MD, Agnes B. Fogo, MD, Mark A. Lusco, MD, Charles E
Thin Glomerular Basement Membranes
Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad Najafian, MD, Charles E
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Acute Rejection, Types II & III (Vascular)
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Diabetic Nephropathy American Journal of Kidney Diseases
Infection in Renal Transplantation: A Case of Acute Q Fever
AJKD Atlas of Renal Pathology: Minimal Mesangial and Mesangial Proliferative Lupus Nephritis (ISN/RPS Class I and II)  Agnes B. Fogo, MD, Mark A. Lusco,
Dense Deposit Disease American Journal of Kidney Diseases
Behzad Najafian, MD, Mark A. Lusco, MD, Laura S. Finn, MD, Charles E
Volume 76, Issue 5, Pages (September 2009)
AJKD Atlas of Renal Pathology: Chronic Antibody-Mediated Rejection
Progressive Systemic Sclerosis
Membranoproliferative Glomerulonephritis
AJKD Atlas of Renal Pathology: Fibrillary Glomerulonephritis
Glomerular disease related to anti-VEGF therapy
Acute Tubular Necrosis
C3 Glomerulonephritis Associated With Complement Factor B Mutation
Sickle Cell Nephropathy
Sarcoidosis American Journal of Kidney Diseases
AJKD Atlas of Renal Pathology: Nail-Patella Syndrome–Associated Nephropathy  Behzad Najafian, MD, Kelly Smith, MD, PhD, Mark A. Lusco, MD, Charles E. Alpers,
Acute Humoral Rejection
AJKD Atlas of Renal Pathology: Heavy Chain Deposition Disease
Cytomegalovirus Infection
Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency
Type III Collagen Glomerulopathy (Collagenofibrotic Glomerulopathy)
Chronic Pyelonephritis
Malignant Hypertension
Postinfectious Glomerulonephritis
Lupus Nephritis: Mesangial and Membranous Forms (WHO II and V)
Lupus Nephritis: Proliferative Forms (WHO III, IV)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Pauci-immune Necrotizing Crescentic Glomerulonephritides: Wegener's Granulomatosis/Microscopic Polyangiitis  Agnes Fogo, MD  American Journal of Kidney.
AJKD Atlas of Renal Pathology: Postinfectious Glomerulonephritis
AJKD Atlas of Renal Pathology: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits  Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad.
Acute Rejection, type I (Interstitial)
AJKD Atlas of Renal Pathology: Pierson Syndrome
Cortical Necrosis American Journal of Kidney Diseases
Collapsing Glomerulopathy
Fibrillary Glomerulonephritis
AJKD Atlas of Renal Pathology: Light Chain Deposition Disease
AJKD Atlas of Renal Pathology: Membranous Nephropathy
Cryoglobulin-Related Glomerulonephritis
AJKD Atlas of Renal Pathology: Thrombotic Microangiopathy
Cyclosporine Toxicity
Pre-eclampsia/Eclampsia
Cholesterol Emboli American Journal of Kidney Diseases
AJKD Atlas of Renal Pathology: Idiopathic Nodular Sclerosis
AJKD Atlas of Renal Pathology: Systemic Sclerosis
Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad Najafian, MD, Charles E
AJKD Atlas of Renal Pathology: Anti–Glomerular Basement Membrane Antibody– Mediated Glomerulonephritis  Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian,
Quiz page: February 2002 American Journal of Kidney Diseases
AJKD Atlas of Renal Pathology: Minimal Change Disease
AJKD Atlas of Renal Pathology: Diabetic Nephropathy
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis
Immunotactoid Glomerulopathy
Light Chain Deposition Disease
Chronic Transplant Glomerulopathy
AJKD Atlas of Renal Pathology: IgA Nephropathy
C1q Nephropathy American Journal of Kidney Diseases
IgA Nephropathy American Journal of Kidney Diseases
Development of Lupus Nephritis in a Patient With Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy  Hideki Wakui, MD, Rie Masai, MD, Shin Okuyama,
AJKD Atlas of Renal Pathology: Fibronectin Glomerulopathy
Acute Renal Failure due to IgM-λ Glomerular Thrombi and MPGN-Like Lesions in a Patient With Angioimmunoblastic T-Cell Lymphoma  Naoto Miura, MD, Keisuke.
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Quiz Page Answers May 2006 American Journal of Kidney Diseases
Amyloid American Journal of Kidney Diseases
Presentation transcript:

IgA Nephropathy American Journal of Kidney Diseases Agnes Fogo, MD  American Journal of Kidney Diseases  Volume 31, Issue 4, Pages E1-E2.2 (April 1998) DOI: 10.1053/S0272-6386(13)90003-2 Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 1A IgA nephropathy with minimal increase in mesangial matrix and cells (normal is less than or equal to 3 cells/mesangial area). The diagnosis must rely on additional immunofluorescence and electron microscopic studies ([A] periodic acid-Schiff, original magnification ×200; [B] Jones' silver stain, original magnification ×400). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 1B IgA nephropathy with minimal increase in mesangial matrix and cells (normal is less than or equal to 3 cells/mesangial area). The diagnosis must rely on additional immunofluorescence and electron microscopic studies ([A] periodic acid-Schiff, original magnification ×200; [B] Jones' silver stain, original magnification ×400). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Moderate diffuse mesangial expansion with increased matrix and cellularity in IgA nephropathy (Jones' silver stain, original magnification ×100). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 3A IgA nephropathy with moderate mesangial expansion with increased matrix and cells ([A] periodic acid-Schiff; [B] Jones' silver stain; original magnification for each ×200). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 3B IgA nephropathy with moderate mesangial expansion with increased matrix and cells ([A] periodic acid-Schiff; [B] Jones' silver stain; original magnification for each ×200). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Increased mesangial cellularity and matrix in IgA nephropathy (Jones' silver stain, original magnification ×400). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 5A IgA nephropathy may have superimposed segmental sclerosis in addition to variable mesangial increase. (A) A small peripheral sclerotic lesion with adhesion is present; (B) more advanced segmental sclerosis is shown ([A] Jones' silver stain; [B] periodic acid-Schiff; original magnification for each ×200). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 5B IgA nephropathy may have superimposed segmental sclerosis in addition to variable mesangial increase. (A) A small peripheral sclerotic lesion with adhesion is present; (B) more advanced segmental sclerosis is shown ([A] Jones' silver stain; [B] periodic acid-Schiff; original magnification for each ×200). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 6 The diagnosis of IgA nephropathy rests on the finding of dominant or codominant IgA mesangial deposits, as shown here. Staining may also be present for IgG and IgM, but not in greater intensity than for IgA. C3 is also often present in the mesangial areas, usually equal to or less than IgA staining (anti-IgA immunofluorescence, original magnification ×200). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 7 Henoch-Schönlein purpura (HSP) also has mesangial IgA deposits, and thus it appears morphologically like IgA nephropathy. Clinicopathological correlation is required to distinguish HSP from IgA nephropathy, but crescents, shown here, are more frequent in biopsied HSP than in IgA nephropathy (Jones's silver stain, original magnification ×100). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 8 Mesangial electron dense deposits and increased mesangial matrix and cellularity in IgA nephropathy (transmission electron microscopy, original magnification ×4,500). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 9 Mesangial electron dense deposits and increased mesangial matrix and cellularity in IgA nephropathy (transmission electron microscopy, original magnification ×8,500). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions

Fig 10 Marked increase in mesangial cellularity and matrix with massive mesangial dense deposits, with some extension of deposits to paramesangial areas. (Left) There is also interposition of cells in the glomerular basement membrane with new basement membrane formation on the endothelial aspect of the interposed cells (transmission electron microscopy, original magnification ×4,800). American Journal of Kidney Diseases 1998 31, E1-E2.2DOI: (10.1053/S0272-6386(13)90003-2) Copyright © 1998 National Kidney Foundation, Inc. Terms and Conditions